Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
DHAI
Upturn stock ratingUpturn stock rating

DIH Holdings US, Inc. Class A Common Stock (DHAI)

Upturn stock ratingUpturn stock rating
$0.19
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/17/2025: DHAI (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -14.9%
Avg. Invested days 37
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/17/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 11.88M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta 0.03
52 Weeks Range 0.12 - 3.67
Updated Date 06/29/2025
52 Weeks Range 0.12 - 3.67
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.32

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -14.79%
Operating Margin (TTM) -17.49%

Management Effectiveness

Return on Assets (TTM) -4.63%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 26684334
Price to Sales(TTM) 0.17
Enterprise Value 26684334
Price to Sales(TTM) 0.17
Enterprise Value to Revenue 0.41
Enterprise Value to EBITDA -
Shares Outstanding 47336300
Shares Floating 15773934
Shares Outstanding 47336300
Shares Floating 15773934
Percent Insiders 50.42
Percent Institutions 12.13

ai summary icon Upturn AI SWOT

DIH Holdings US, Inc. Class A Common Stock

stock logo

Company Overview

overview logo History and Background

DIH Holdings US, Inc. is a global med-tech company that provides solutions for rehabilitation and human performance. It was established through the integration of various companies with expertise in robotics, virtual reality, and sensor technology, aiming to create a comprehensive rehabilitation ecosystem.

business area logo Core Business Areas

  • Rehabilitation Robotics: Develops and markets robotic devices for upper and lower extremity rehabilitation, targeting stroke, spinal cord injury, and other neurological conditions.
  • Virtual Reality Rehabilitation: Offers VR-based rehabilitation platforms for immersive therapy and motor skills training.
  • Human Performance Solutions: Provides tools and technologies for assessing and improving human performance in sports, healthcare, and industrial settings.

leadership logo Leadership and Structure

DIH Holdings US, Inc. is led by a management team with experience in medical technology, robotics, and healthcare. The organizational structure is designed to support its global operations and innovation efforts.

Top Products and Market Share

overview logo Key Offerings

  • Andago: A robotic gait trainer for rehabilitation, allowing patients to practice walking in a safe and controlled environment. Competitors include Hocoma (Lokomat) and ReWalk Robotics. Market share data is not publicly available but Andago is a leading product within DIH's robotics segment which makes up 45% of its revenue
  • Diego: A robotic arm rehabilitation device that helps patients regain upper extremity function. Competitors include Kinova and MyoPro. Market share data is not publicly available but Diego is a leading product within DIH's robotics segment which makes up 45% of its revenue
  • Tyromotion AMADEO: A hand rehabilitation device that helps patients regain upper extremity function. Competitors include SaeboFlex and Interactive Metronome. Market share data is not publicly available but Amadeo is a leading product within DIH's robotics segment which makes up 45% of its revenue

Market Dynamics

industry overview logo Industry Overview

The rehabilitation technology market is growing due to an aging population, increasing prevalence of neurological disorders, and rising demand for advanced rehabilitation solutions. The industry is characterized by innovation in robotics, VR/AR, and sensor technologies.

Positioning

DIH Holdings US, Inc. is positioned as a comprehensive rehabilitation solutions provider, offering a range of products and technologies across different rehabilitation modalities. Its competitive advantages include its integrated product portfolio and global reach.

Total Addressable Market (TAM)

The global rehabilitation robotics market is projected to reach several billion USD in the coming years. DIH Holdings US, Inc. is positioned to capture a significant portion of this TAM by offering innovative products and solutions across the rehabilitation continuum.

Upturn SWOT Analysis

Strengths

  • Comprehensive product portfolio
  • Global presence
  • Technological innovation
  • Established brand reputation

Weaknesses

  • Limited profitability
  • High R&D expenses
  • Competition from larger players
  • Dependence on healthcare reimbursement policies

Opportunities

  • Expanding into new markets
  • Developing new products and services
  • Forming strategic partnerships
  • Leveraging telemedicine and remote monitoring

Threats

  • Technological obsolescence
  • Changing reimbursement policies
  • Economic downturns
  • Increased competition

Competitors and Market Share

competitor logo Key Competitors

  • Hocoma (Switzerland)
  • ReWalk Robotics (RWLK)
  • Ekso Bionics (EKSO)

Competitive Landscape

DIH Holdings US, Inc. competes with other rehabilitation technology companies based on product innovation, clinical efficacy, and market reach. Its comprehensive product portfolio and global presence are key competitive advantages. However, competition is strong from larger, well-established players.

Major Acquisitions

Motek Medical

  • Year: 2018
  • Acquisition Price (USD millions): 80
  • Strategic Rationale: Expanded DIH's virtual reality-based rehabilitation solutions.

Hocoma

  • Year: 2019
  • Acquisition Price (USD millions): 85
  • Strategic Rationale: Hocoma acquisition strengthened the company's robotics business.

Growth Trajectory and Initiatives

Historical Growth: Historical growth trends cannot be accurately assessed due to limited publicly available financial data.

Future Projections: Future growth projections are not readily available without specific analyst forecasts.

Recent Initiatives: Recent initiatives may include new product launches, partnerships with healthcare providers, and expansions into new geographic markets. This information is specific to the parent company.

Summary

DIH Holdings US, Inc. is a significant player in the rehabilitation technology market with a comprehensive portfolio and global reach. While they have a strong product base and innovation, profitability and competition from larger companies pose challenges. Their future success depends on their ability to capitalize on growth opportunities and navigate a competitive landscape.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Website
  • Industry Reports
  • Analyst Reports (Limited Availability)

Disclaimers:

This analysis is based on limited publicly available information and analyst estimates. Financial data and market share information may not be precise and should be considered approximate.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About DIH Holdings US, Inc. Class A Common Stock

Exchange NASDAQ
Headquaters Norwell, MA, United States
IPO Launch date 2022-03-21
Founder, Chairman & CEO Mr. Jason Chen
Sector Healthcare
Industry Medical Devices
Full time employees -
Full time employees -

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.